Transrectal ultrasound used in office practice to aid in the diagnosis of carcinoma of the prostate.
Transrectal ultrasound and TRUS-guided needle biopsy was studied in office practice to detect prostate cancer in men with palpably irregular prostates or elevated tumor markers (PAP/PSA). Of 330 men examined, 118 had TRUS biopsy: 33 were positive for adenocarcinoma, 13 were small volume, low stage lesions treated by R.R.P. Twenty-eight percent of all patients biopsied had adenocarcinoma: 11% (13) had low volume, low stage disease potentially curable by radical surgery, representing 4% of the total studied. TRUS in combination with markers does aid in the diagnosis of low stage prostatic adenocarcinoma. It is a practical, useful, office-based urologic procedure.